AmeriCann /

Our News

Statement about Extension to Commencement of Adult-Use in Massachusetts

AmeriCann • December 29, 2016

Statement by AmeriCann CEO, Tim Keogh, about extension to commencement of Massachusetts recreational use of marijuana program

AmeriCann, Inc. (OTCQX: ACAN) respects the need to create a safe and responsible regulatory structure for adult-use cannabis in Massachusetts, and appreciates that the legislature is taking a thoughtful approach to the implementation of this law, while also respecting the will of the voters.

In addition to our involvement with the Massachusetts cannabis industry our team has first-hand experience with Colorado’s adult-use program and understands the importance of establishing rules and regulations that are effective and reasonable.

The approval of Question 4 is not simply an extension of the Medical-Use of Marijuana Program; an entirely new regulatory structure needs to be created.

Massachusetts has the opportunity to become a model for other states that are considering or choose to adopt regulation over prohibition.

Our team looks forward to working with the Legislature to establish a regulatory structure that works for the citizens of Massachusetts under this new timeline.

For Interviews:

Tim Keogh


AmeriCann, Inc.



About AmeriCann

AmeriCann, Inc. (OTCQX: ACAN) is a publicly traded company that plans to develop and lease sustainable, state-of-the-art medical cannabis cultivation properties. The Company has over 1,000,000 square feet of facilities in the planning and design stages of development.  The Company has designed a proprietary line of cannabis infused products which will be branded and licensed to companies in regulated markets.

AmeriCann, Inc. is a Certified B Corp, an acknowledgment of the company’s commitment to social and environmental ethics, transparency and accountability. AmeriCann became the first public cannabis company to earn this respected accreditation. More information about the Company is available at:

About Massachusetts Medical Cannabis Center

Full Build - 1,000,000 sf

Full Build – 1,000,000 sf

The Massachusetts Medical Cannabis Center is approved for nearly 1,000,000 square feet of medical cannabis cultivation and processing in Freetown, Massachusetts. The state-of-the-art, sustainable, greenhouse project will consist of multiple planned phases for tenants in the Massachusetts medical marijuana market.  AmeriCann’s Cannopy System uniquely combines expertise from traditional horticulture, lean manufacturing, regulatory compliance and cannabis cultivation to create superior facilities and procedures.

The first phase potential of the project consists of a 160,000 square feet of cultivation and processing infrastructure. AmeriCann can expand the first phase based on patient demand without any disruption to the ongoing operations.

In October, AmeriCann completed the acquisition of the 53-acre Massachusetts property from Boston Beer Company (SAM-NYSE) for $4,475,000 cash.

About Extension

On December 28th, 2016, The Massachusetts House and Senate passed a six-month extension in the retail sale of marijuana for recreational use by cannabis shops from Jan. 1, 2018, until July 1, 2018.

ACAN Releases Designs for 345,000 sq. ft. Mass. Cannabis Manufacturing and Cultivation Project

AmeriCann Releases Designs for 345,000 sq. ft. Building at Massachusetts Cannabis Manufacturing and Cultivation Project Company plans to own and operate large-scale extraction and product…

AmeriCann • October 9, 2018

AmeriCann to Host Ground Breaking Celebration Sept. 25th

New facility allows for 987,000 sq. ft. of cannabis cultivation and processing infrastructure\  (Denver, CO) AmeriCann, Inc. (OTCQB: ACAN), an agricultural-technology company that is developing…

AmeriCann • September 12, 2018